Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: synchro who wrote (2679)	9/12/1999 12:20:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4676

Actuary Age 29? I scanned through your posts, I'd have guessed a high paid investment advisor what are you doing hanging out with so many "punters"? Can you tell us why you check in on the Isis thread from time to time, I've been warned off Isis once or twice, but you look like a pretty savvy trader, and somebody must have said something to you about Isis' particular flavor of antisense to keep you coming back? To what degree do you understand the science? I see you are from the camp that is wise to the folly of putting all your eggs in one basket, the aphorism 'pigs get slaughtered' came up in at least one of your posts. When is 'investing' courageous, when it is foolish? I've been ridiculed one too many times in the last few weeks, for having a single stock, an investment which I believe I understand. But I'm smart enough to ask for advice when I see a chance. Finally, although I was disappointed with Crusade, I hear JMS is working on another Teevee series, tho not set in the B5 universe. Also, wouldn't you love to see a movie--I'd have Andreas Katsulas in the lead role, plus Jurasik and Furlan of course.

To: synchro who wrote (2679)	9/12/1999 2:35:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 4676

Even if this overly broad statement was true, not to many cats, dogs & pigs went up 30% recently, a time period that contained two items of clinical significance. Now lets see the overly broad statement holds up well in practive. Granted lots of biotechs did well - the NAZ did very well. The huge valuation disparity between large cap and the rest of the market is coming closer into balance (and has a ways to go yet long term) I have 15 stocks I follow in the broad definition of biotech. Advancers last week VICL, TTP, ISIP, MLNM, LGND, TRIBY, IMCL, CHIR (I hold VICL, ISIP, TTP & TRIBY) of these, only VICL had no news items, TTP looks to have benefited from both an investor's conference where the CEO spoke & a followup article at The Streat.com + a report. Staying even xoma, onxx nzym, mre, imnr, ctic, axys Most of these had news, on balance, I would assess their news items as having less clinical significance. My sampling is not broad enough to make a conclusive statement, and perhaps I should have gone to another chart site where I could have put in 10 days as the duration, rather than the 5 allowed with YAHOO, but it does not look like the facts support your theory. Rather market response may likely have been a combination of news, and mo-players trying for short term pops. Next time, you may want to do a little more homework before making desparaging comments such as this <<Every cat, dog and pig in the biotech sector went up during the past two weeks.>> Scott